Red oil A5 inhibits proliferation and induces apoptosis in pancreatic cancer cells

World Journal of Gastroenterology

Volumn 10, Issue 1, 2004, Pages 105-111

  Dong, Mi Lian ^a   Ding, Xian Zhong ^b   Adrian, Thomas E ^b  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CELL DNA; CYTOCHROME C; DNA FRAGMENT; FISH OIL; MONOCLONAL ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ARGININE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 3; PROPIDIUM IODIDE; RED OIL A5; THYMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; COULTER COUNTER; CYTOSOLIC FRACTION; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; PANCREAS CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; STAINING; TIME SERIES ANALYSIS; WESTERN BLOTTING;

EID: 0346055106     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i1.105     Document Type: Article

References (46)

1. Blackstock AW, Cox AD, Tepper JE. Treatment of pancreatic cancer: Current limitations, future possibilities. Oncology 1996; 10: 301-307
2. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS. One hundred and forty-five consecutive pancreaticoduodenetomies without mortality. Ann Surg 1993; 217: 430-435
3. Doll R, Reto R. Mortality in relation to smoking: 20 years observations on male British doctors. Br Med J 1976; 2: 1525-1536
4. Abbruzzese JL. Past and present treatment of pancreatic adenocarcinoma: Chemotherapy as a standard treatment modality. Semin Oncol 2002; 29(6 Suppl 20): 2-8
5. Ozawa F, Friess H, Tempia-Caliera A, Kleeff J, Buchler MW. Growth factors and their receptors in pancreatic cancer. Teratog Carcinog Mutagen 2001; 21: 27-44
6. Kleeff J, Friess H, Berberat PO, Martignoni ME, Z'graggen K, Buchler MW. Pancreatic cancer - New aspects of molecular biology research. Swiss Surg 2000; 6: 231-234
7. Silverberg E, Boring CC, Squires TS. Cancer Statistics, 1990. CA Cancer J Clin 1990; 40: 9-26
8. Hunstad DA, Norton JA. Management of pancreatic carcinoma. Surg Oncol 1995; 4: 61-74
9. Neri B, Cini G, Doni L, Fulignati C, Turrini M, Pantalone D, Mini E, De Luca Cardillo C, Fioretto LM, Ribecco AS, Moretti R, Scatizzi M, Zocchi G, Quattrone A. Weekly gemcitabine plus Epirubicin as effective chemotherapy for advanced pancreatic cancer: A multicenter phase II study. Br J Cancer 2002; 87: 497-501
10. Ding XZ, Tong WG, Adrian TE. Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer. Pancreatology 2001; 1: 291-299
11. Su Z, Lebedeva IV, Gopalkrishnan RV, Goldstein NI, Stein CA, Reed JC, Dent P, Fisher PB. A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc Natl Acad Sci U S A 2001; 98: 10332-10337
12. Fay MP, Freedman LS, Clifford CK, Midthune DN. Effect of different types and amounts of fat on the development of mammary tumors in rodents: A review. Cancer Res 1997; 57: 3979-3988
13. Ravichandran D, Cooper A, Johnson CD. Effect of lithium gamma-linolenate on the growth of experimental human pancreatic carcinoma. Br J Surg 1998; 85: 1201-1205
14. Hawkins RA, Sangster K, Arends MJ. Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J Pathol 1998; 185: 61-70
15. Ravichandran D, Cooper A, Johnson CD. Growth inhibitory effect of lithium gammalinolenate on pancreatic cancer cell lines: The influence of albumin and iron. Eur J Cancer 1998; 34: 188-192
16. Falconer JS, Ross JA, Fearon KC, Hankins RA, O'Riordain MG, Carter DC. Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines. Br J Cancer 1994; 69: 826-832
17. Clerc P, Bensaadi N, Pradel P, Estival A, Clemente F, Vaysee N. Lipid-dependent proliferation of pancreatic cancer cell lines. Cancer Res 1991; 51: 3633-3638
18. Tisdale MJ. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia. Nutrition 1996; 12(1 Suppl.): S31-33
19. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999; 81: 80-86
20. Von Hoff DD, Bearss D. New drugs for patients with pancreatic cancer. Curr Opin Oncol 2002; 14: 621-627
21. Barber MD, Fearson KC, Tisdale MJ, McMillan DC, Ross JA. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 2001; 40: 118-124
22. Tang DG, La E, Kern J, Kehrer JP. Fatty acid oxidation and signaling in apoptosis. Biol Chem 2002; 383: 425-442
23. Hawkins RA, Sangster K, Arends MJ. Apoptotic death of pancreatic cancer cells induced by polyunsaturated fatty acids varies with double bond number and involves an oxidative mechanism. J Pathol 1998; 185: 61-70
24. Huang PL, Zhu SN, Lu SL, Dai ZS, Jin YL. Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells. World J Gastroenterol 2000; 6: 295-297
25. Calviello G, Palozza P, Franceschelli P, Frattucci A, Piccioni E, Tessitore L, Bartoli GM. Eicosapentaenoic acid inhibits the growth of liver preneoplastic lesions and alters membrane phospholipid composition and peroxisomal beta-oxidation. Nutr Cancer 1999; 34: 206-212
26. Bartsch H, Nair J, Owen RW. Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: Emerging evidence for their role as risk modifiers. Carcinogenesis 1999; 20: 2209-2218
27. Lai PB, Ross JA, Fearon KC, Anderson JD, Carter DC. Cell cycle arrest and induction of apoptosis in pancreatic cancer cells exposed to eicosapentaenoic acid in vitro. Br J Cancer 1996; 74: 1375-1383
28. Karmali RA, Donner A, Gobel S, Shimamura T. Effect of n-3 and n-6 fatty acids on 7, 12 dimethylbenz a anthracene-induced mammary tumorigenesis. Anticancer Res 1989; 9: 1161-1167
29. Rose DP, Connolly JM. Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice. Int J Oncol 1999; 15: 1011-1015
30. Larsen LN, Hovik K, Bremer J, Holm KH, Myhren F, Borretzen B. Heneicosapentaenoate (21: 5n-3): Its incorporation into lipids and its effects on arachidonic acid and eicosanoid synthesis. Lipids 1997; 32: 707-714
31. Noguchi M, Earashi M, Minami M, Kinoshita K, Miyazaki I. Effects of eicosapentaenoic and docosahexaenoic acid on cell growth and prostaglandin E and Leukotriene B production by a human breast cancer cell line (MDA-MB-231). Oncology 1995; 52: 458-464
32. Qanungo S, Basu A, Das M, Haldar S. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene 2002; 21: 4149-4157
33. Bossy-Wetzel E, Green DR. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 1999; 274: 17484-17490
34. Tong WG, Ding XZ, Witt RC, Adrian TE. Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther 2002; 1: 929-935
35. Gerhard MC, Schmid RM, Hacke G. Analysis of the cytochrome c-dependent apoptosis apparatus in cells from human pancreatic carcinoma. Br J Cancer 2002; 86: 893-898
36. Mouria M, Gukovskaya AS, Jung Y, Buechler P, Hines OJ, Reber HA, Pandol SJ. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int J Cancer 2002; 10: 761-769
37. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997; 275: 1132-1136
38. Thornberry NA, Lazebnik Y. Caspase: Enemies within. Science 1998; 281: 1312-1316
39. Mancini M, Nicholson DW, Roy S, Thomberry NA, Peterson EP, Casciola-Rosen LA, Rosen A. The caspase-3 precursor has a cytosolic and mitochondrial distribution: Implications for apoptotic signaling. J Cell Biol 1998; 140: 1485-1495
40. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT. Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science 1997; 278: 294-298
41. Kobayashi D, Sasaki M, Watanabe N. Caspase-3 activation downstream from reactive oxygen species in heat-induced apoptosis of pancreatic carcinoma cells carrying a mutant p53 gene. Pancreas 2001; 22: 255-260
42. Virkajarvi N, Paakko P, Soini Y. Apoptotic index and apoptosis influencing proteins bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma. Histopathology 1998; 33: 432-439
43. Pirocanac EC, Nassirpour R, Yang M, Wang J, Nardin SR, Gu J, Fang B, Moossa AR, Hoffman RM, Bouvet M. Bax-induction gene therapy of pancreatic cancer. J Surg Res 2002; 106: 346-351
44. Kirsch DG, Doseff A, Chau BN, Lim DS, De Souza-Pinto NC, Hansford R, Kastan MB, Lazebnik YA, Hardwick JM. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J Biol Chem 1999; 274: 21155-21161
45. Decker P, Isenberg D, Muller S. Inhibition of caspase-3-mediated poly (ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis. J Biol Chem 2000; 275: 9043-9046
46. Sellers WR, Fisher DE. Apoptosis and cancer drug targeting. J Clin Invest 1999; 104: 1655-1661